Institutions / Bellevue Group AG
Bellevue Group AG
CIK 1674546 · Institution · as of Dec 31, 2025
Portfolio value
$5.28B
Positions
176
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 176 →
| Company | Value | % of portfolio |
|---|---|---|
| Revolution Medicines, Inc. | $398.71M | 7.6% |
| Argenx SE | $388.40M | 7.4% |
| Ionis Pharmaceuticals Inc | $379.90M | 7.2% |
| Vertex Pharmaceuticals Inc / Ma | $308.79M | 5.9% |
| Neurocrine Biosciences Inc | $241.58M | 4.6% |
| Avidity Biosciences, Inc. | $189.77M | 3.6% |
| Intuitive Surgical Inc | $182.38M | 3.5% |
| Scholar Rock Holding Corp | $178.69M | 3.4% |
| Alnylam Pharmaceuticals Inc | $177.31M | 3.4% |
| Abbott Laboratories | $165.00M | 3.1% |
| Amicus Therapeutics Inc | $152.87M | 2.9% |
| Boston Scientific Corp | $148.71M | 2.8% |
| Viridian Therapeutics, Inc. | $135.64M | 2.6% |
| Stryker Corp | $126.73M | 2.4% |
| Nuvalent, Inc. | $104.36M | 2.0% |
| Krystal Biotech, Inc. | $101.16M | 1.9% |
| Celldex Therapeutics, Inc. | $98.26M | 1.9% |
| Immunocore Holdings Plc-AdrIMCR | $97.08M | 1.8% |
| Edwards Lifesciences Corp | $88.92M | 1.7% |
| Vera Therapeutics, Inc. | $85.99M | 1.6% |
| Medtronic plc | $73.64M | 1.4% |
| Relay Therapeutics, Inc. | $70.60M | 1.3% |
| Idexx Laboratories Inc /De | $63.96M | 1.2% |
| Unitedhealth Group Inc | $57.83M | 1.1% |
| Dexcom Inc | $56.24M | 1.1% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.